Joincare Pharmaceutical Group Industry Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Net Sales

3,758.05

4,040.78

3,667.81

3,620.63

3,847.54

4,293.10

3,942.16

Other Operating Income

0.00

Total Operating income

3,758.05

4,040.78

3,667.81

3,620.63

3,847.54

4,293.10

3,942.16

Raw Material Cost

1,490.86

1,622.56

1,491.52

1,430.38

1,507.26

1,663.37

1,574.12

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

22.83

22.90

28.29

22.52

38.72

33.73

40.30

Selling and Distribution Expenses

1,239.79

1,152.20

1,158.62

1,092.43

1,148.14

1,330.47

1,218.32

Other Expenses

25.13

24.08

33.57

26.42

25.76

30.21

33.53

Total Expenditure (Excl Depreciation)

3,004.74

3,038.41

3,014.15

2,809.49

2,951.74

3,329.65

3,168.02

Operating Profit (PBDIT) excl Other Income

753.3

1002.4

653.7

811.1

895.8

963.5

774.0999999999999

Other Income

187.50

156.48

328.70

55.76

131.68

141.52

221.52

Operating Profit (PBDIT)

1,159.82

1,379.11

1,017.24

1,049.72

1,185.09

1,336.62

1,041.26

Interest

22.83

22.90

28.29

22.52

38.72

33.73

40.30

Exceptional Items

-8.41

1.71

-11.76

13.84

-20.74

1.16

20.58

Gross Profit (PBDT)

2,267.19

2,418.22

2,176.29

2,190.25

2,340.28

2,629.73

2,368.04

Depreciation

226.62

214.33

235.72

249.53

Profit Before Tax

901.96

1,131.30

762.86

826.71

889.91

1,068.32

772.02

Tax

119.03

189.99

206.52

99.80

124.39

161.42

180.71

Provisions and contingencies

0.00

Profit After Tax

349.15

435.79

275.01

335.14

336.63

439.80

359.13

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

349.15

435.79

275.01

335.14

336.63

439.80

359.13

Share in Profit of Associates

0.00

Minority Interest

453.44

525.34

274.04

402.35

434.49

485.30

247.09

Other related items

0.00

Consolidated Net Profit

802.59

961.12

549.05

737.48

771.12

925.10

606.22

Equity Capital

0.00

Face Value

1.0

Reserves

14,645.40

14,644.95

14,534.72

14,487.77

14,312.14

14,234.87

13,755.90

Earnings per share (EPS)

0.19

0.24

0.15

0.18

0.24

0.19

Diluted Earnings per share

0.19

0.24

0.15

0.18

0.24

0.19

Operating Profit Margin (Excl OI)

19.84%

24.65%

12.93%

21.53%

21.25%

22.35%

14.46%

Gross Profit Margin

30.03%

33.61%

26.64%

28.75%

29.26%

30.38%

25.91%

PAT Margin

9.29%

10.78%

7.5%

9.26%

8.75%

10.24%

9.11%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Jun 2025 is -2.33% vs -6.45% in Jun 2024

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 4.09% vs 2.94% in Jun 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -7.70% vs 1.18% in Jun 2024

Interest

YoY Growth in quarter ended Jun 2025 is -41.09% vs 4.59% in Jun 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Joincare Pharmaceutical Group Industry Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(CNY)

Change(%)

Net Sales

3,758.05

Other Operating Income

0.00

Total Operating income

3,758.05

Raw Material Cost

1,490.86

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

22.83

Selling and Distribution Expenses

1,239.79

Other Expenses

25.13

0.00

25.13

Total Expenditure (Excl Depreciation)

3,004.74

Operating Profit (PBDIT) excl Other Income

753.31

0.00

753.31

Other Income

187.50

Operating Profit (PBDIT)

1,159.82

Interest

22.83

Exceptional Items

-8.41

Gross Profit (PBDT)

2,267.19

Depreciation

226.62

Profit Before Tax

901.96

Tax

119.03

Provisions and contingencies

0.00

Profit After Tax

349.15

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

349.15

Share in Profit of Associates

0.00

Minority Interest

453.44

Other related items

0.00

Consolidated Net Profit

802.59

Equity Capital

0.00

Face Value

1.00

0.00

Reserves

14,645.40

Earnings per share (EPS)

0.19

Diluted Earnings per share

0.19

Operating Profit Margin (Excl OI)

19.84%

0.00

19.84%

Gross Profit Margin

30.03%

0.00

30.03%

PAT Margin

9.29%

0.00

9.29%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 375.80 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is -7.00% vs 10.17% in Mar 2025

YoY Growth in quarter ended Jun 2025 is -2.33% vs -6.45% in Jun 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 80.26 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is -16.49% vs 75.06% in Mar 2025

YoY Growth in quarter ended Jun 2025 is 4.09% vs 2.94% in Jun 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 97.23 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is -20.47% vs 77.57% in Mar 2025

YoY Growth in quarter ended Jun 2025 is -7.70% vs 1.18% in Jun 2024

Quarterly - Interest

Interest 2.28 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is -0.44% vs -19.08% in Mar 2025

YoY Growth in quarter ended Jun 2025 is -41.09% vs 4.59% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 19.84%

in Jun 2025

Figures in %

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024